This novel cannabinoid offers promise for some health disorders. - Psychology Today
This novel cannabinoid offers promise for some health disorders. Psychology Today
News Wire
LIVEReal-time CBD & hemp news from 16+ industry sources. Updated every 2 hours.
364 stories6 sources
CBD ‘Improves Cognitive Decline Associated With Aging,’ Study Shows - Marijuana Moment
CBD ‘Improves Cognitive Decline Associated With Aging,’ Study Shows Marijuana Moment
Study: Many pregnant women uncertain of marijuana risks even as use increases - UF Health - University of Florida Health
Study: Many pregnant women uncertain of marijuana risks even as use increases UF Health - University of Florida Health
Clinical Trial Tests Effects of CBD on Liver Enzyme Levels - Cannabis Science and Technology
Clinical Trial Tests Effects of CBD on Liver Enzyme Levels Cannabis Science and Technology
Cannabis Seed Oil Has 'Superior Effectiveness' In Healing Wounds Compared To Conventional Antibiotics, Study Shows - Marijuana Moment
Cannabis Seed Oil Has 'Superior Effectiveness' In Healing Wounds Compared To Conventional Antibiotics, Study Shows Marijuana Moment
Cannabinoid Clinical Trial Pipeline Gains Momentum: 50+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight - Yahoo Finance
Cannabinoid Clinical Trial Pipeline Gains Momentum: 50+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight Yahoo Finance
Vaping Produces a Chemical that Destroys Human Tissue, Research Shows - University of California, Merced
Vaping Produces a Chemical that Destroys Human Tissue, Research Shows University of California, Merced
Gleaning from recent FDA warning letters - SupplySide Supplement Journal
Gleaning from recent FDA warning letters SupplySide Supplement Journal
Low doses of CBD may harm some people’s liver function, study warns - Euronews.com
Low doses of CBD may harm some people’s liver function, study warns Euronews.com
KC-based American Shaman presses forward with 7-OH drug, despite FDA warning letter - The Business Journals
KC-based American Shaman presses forward with 7-OH drug, despite FDA warning letter The Business Journals
Does cannabidiol reduce the adverse effects of cannabis in schizophrenia? A randomised, double-blind, cross-over trial - Nature
Does cannabidiol reduce the adverse effects of cannabis in schizophrenia? A randomised, double-blind, cross-over trial Nature
Daily CBD Use at Consumer-Level Doses May Elevate Liver Enzymes, FDA-Led Trial Shows - Pharmacy Times
Daily CBD Use at Consumer-Level Doses May Elevate Liver Enzymes, FDA-Led Trial Shows Pharmacy Times
Cannabidiol demonstrates safety, mixed efficacy for severe behavior problems in boys with autism - Contemporary Pediatrics
Cannabidiol demonstrates safety, mixed efficacy for severe behavior problems in boys with autism Contemporary Pediatrics
Even low doses of CBD may cause harm to the liver in some people, FDA study finds - NBC News
Even low doses of CBD may cause harm to the liver in some people, FDA study finds NBC News
FDA Plan To Include Hemp-Derived Cannabinoids In Federal Adverse Health Event Reporting System Goes To White House For Approval - Marijuana Moment
FDA Plan To Include Hemp-Derived Cannabinoids In Federal Adverse Health Event Reporting System Goes To White House For Approval Marijuana Moment
CBD Might Help Children with Autism, but More Research Needed - UC San Diego Today
CBD Might Help Children with Autism, but More Research Needed UC San Diego Today
Federal Bill Would 'Effectively' Ban All Consumable Hemp Products—'Including CBD'—Congressional Researchers Say - Marijuana Moment
Federal Bill Would 'Effectively' Ban All Consumable Hemp Products—'Including CBD'—Congressional Researchers Say Marijuana Moment
What is CBD oil: Know its health benefits, uses, and scientific backing behind the cannabinoid trend - The Times of India
What is CBD oil: Know its health benefits, uses, and scientific backing behind the cannabinoid trend The Times of India
CBD Gummies Study Reveals Inconsistent Product Labeling - Cannabis Science and Technology
CBD Gummies Study Reveals Inconsistent Product Labeling Cannabis Science and Technology
An open-label phase I comparator-controlled clinical trial to assess tolerability and pharmacokinetics of IHL-675 A a fixed dose combination of cannabidiol plus hydroxychloroquine in healthy volunteers - Nature
An open-label phase I comparator-controlled clinical trial to assess tolerability and pharmacokinetics of IHL-675 A a fixed dose combination of cannabidiol plus...
Showing 301–320 of 364 stories tagged #science